Lisa Marie Schmitz, Nicolai Kreitli, Lisa Obermaier, Nadine Weber, Michael Rychlik, Largus T Angenent
{"title":"从电力到维生素:利用微生物蛋白质系统从可再生电力和二氧化碳中生产叶酸(维生素 B9)。","authors":"Lisa Marie Schmitz, Nicolai Kreitli, Lisa Obermaier, Nadine Weber, Michael Rychlik, Largus T Angenent","doi":"10.1016/j.tibtech.2024.06.014","DOIUrl":null,"url":null,"abstract":"<p><p>We recently proposed a two-stage Power-to-Protein technology to produce microbial protein from renewable electric power and CO<sub>2</sub>. Two stages were operated in series: Clostridium ljungdahlii in Stage A to reduce CO<sub>2</sub> with H<sub>2</sub> into acetate, and Saccharomyces cerevisiae in Stage B to utilize O<sub>2</sub> and produce microbial protein from acetate. Renewable energy can be used to power water electrolysis to produce H<sub>2</sub> and O<sub>2</sub>. A drawback of Stage A was the need for continuous vitamin supplementation. In this study, by using the more robust thermophilic acetogen Thermoanaerobacter kivui instead of C. ljungdahlii, vitamin supplementation was no longer needed. Additionally, S. cerevisiae produced folate when grown with acetate as a sole carbon source, achieving a total folate concentration of 6.7 mg per 100 g biomass with an average biomass concentration of 3 g l<sup>-1</sup>. The developed Power-to-Vitamin system enables folate production from renewable power and CO<sub>2</sub> with zero or negative net-carbon emissions.</p>","PeriodicalId":23324,"journal":{"name":"Trends in biotechnology","volume":null,"pages":null},"PeriodicalIF":14.3000,"publicationDate":"2024-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Power-to-vitamins: producing folate (vitamin B<sub>9</sub>) from renewable electric power and CO<sub>2</sub> with a microbial protein system.\",\"authors\":\"Lisa Marie Schmitz, Nicolai Kreitli, Lisa Obermaier, Nadine Weber, Michael Rychlik, Largus T Angenent\",\"doi\":\"10.1016/j.tibtech.2024.06.014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We recently proposed a two-stage Power-to-Protein technology to produce microbial protein from renewable electric power and CO<sub>2</sub>. Two stages were operated in series: Clostridium ljungdahlii in Stage A to reduce CO<sub>2</sub> with H<sub>2</sub> into acetate, and Saccharomyces cerevisiae in Stage B to utilize O<sub>2</sub> and produce microbial protein from acetate. Renewable energy can be used to power water electrolysis to produce H<sub>2</sub> and O<sub>2</sub>. A drawback of Stage A was the need for continuous vitamin supplementation. In this study, by using the more robust thermophilic acetogen Thermoanaerobacter kivui instead of C. ljungdahlii, vitamin supplementation was no longer needed. Additionally, S. cerevisiae produced folate when grown with acetate as a sole carbon source, achieving a total folate concentration of 6.7 mg per 100 g biomass with an average biomass concentration of 3 g l<sup>-1</sup>. The developed Power-to-Vitamin system enables folate production from renewable power and CO<sub>2</sub> with zero or negative net-carbon emissions.</p>\",\"PeriodicalId\":23324,\"journal\":{\"name\":\"Trends in biotechnology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":14.3000,\"publicationDate\":\"2024-08-22\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Trends in biotechnology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://doi.org/10.1016/j.tibtech.2024.06.014\",\"RegionNum\":1,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Trends in biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1016/j.tibtech.2024.06.014","RegionNum":1,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
我们最近提出了一种两阶段电力转化蛋白质技术,利用可再生电力和二氧化碳生产微生物蛋白质。两个阶段串联运行:梭菌在 A 阶段用 H2 将 CO2 还原成醋酸盐,而酿酒酵母则在 B 阶段利用 O2 并从醋酸盐生产微生物蛋白质。可再生能源可用于水电解产生 H2 和 O2。阶段 A 的缺点是需要持续补充维生素。在这项研究中,通过使用更强健的嗜热醋酸菌 Thermoanaerobacter kivui 代替 C. ljungdahlii,就不再需要补充维生素了。此外,在以醋酸盐为唯一碳源的情况下,S. cerevisiae 也能产生叶酸,每 100 克生物量的总叶酸浓度达到 6.7 毫克,平均生物量浓度为 3 克升-1。所开发的 "从电力到维生素 "系统可利用可再生能源和二氧化碳生产叶酸,净碳排放量为零或负。
Power-to-vitamins: producing folate (vitamin B9) from renewable electric power and CO2 with a microbial protein system.
We recently proposed a two-stage Power-to-Protein technology to produce microbial protein from renewable electric power and CO2. Two stages were operated in series: Clostridium ljungdahlii in Stage A to reduce CO2 with H2 into acetate, and Saccharomyces cerevisiae in Stage B to utilize O2 and produce microbial protein from acetate. Renewable energy can be used to power water electrolysis to produce H2 and O2. A drawback of Stage A was the need for continuous vitamin supplementation. In this study, by using the more robust thermophilic acetogen Thermoanaerobacter kivui instead of C. ljungdahlii, vitamin supplementation was no longer needed. Additionally, S. cerevisiae produced folate when grown with acetate as a sole carbon source, achieving a total folate concentration of 6.7 mg per 100 g biomass with an average biomass concentration of 3 g l-1. The developed Power-to-Vitamin system enables folate production from renewable power and CO2 with zero or negative net-carbon emissions.
期刊介绍:
Trends in Biotechnology publishes reviews and perspectives on the applied biological sciences, focusing on useful science applied to, derived from, or inspired by living systems.
The major themes that TIBTECH is interested in include:
Bioprocessing (biochemical engineering, applied enzymology, industrial biotechnology, biofuels, metabolic engineering)
Omics (genome editing, single-cell technologies, bioinformatics, synthetic biology)
Materials and devices (bionanotechnology, biomaterials, diagnostics/imaging/detection, soft robotics, biosensors/bioelectronics)
Therapeutics (biofabrication, stem cells, tissue engineering and regenerative medicine, antibodies and other protein drugs, drug delivery)
Agroenvironment (environmental engineering, bioremediation, genetically modified crops, sustainable development).